Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neurogenic Orthostatic Hypotension: early-phase trial registry
4 of 5 indexed Neurogenic Orthostatic Hypotension trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Neurogenic Orthostatic Hypotension: 5 US clinical trials tracked, 4 recruiting.
Neurogenic Orthostatic Hypotension is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt University Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition neurogenic-orthostatic-hypotension
OPEN 4 | RECR 80% | LATE 1 | EARLY 2 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)
Neurogenic Orthostatic Hypotension lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neurogenic Orthostatic Hypotension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neurogenic Orthostatic Hypotension is recruiting above its size-band peers.
4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neurogenic Orthostatic Hypotension research.
Vanderbilt University Medical Center accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Neurogenic Orthostatic Hypotension trials plan to enrol fewer than 100 people.
Median target enrolment is 31 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Neurogenic Orthostatic Hypotension research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Natural History Study of Synucleinopathies
NYU Langone Health
NCT01799915
CPAP for the Treatment of Supine Hypertension
Vanderbilt University Medical Center
NCT05489575
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Vanderbilt University Medical Center
NCT04620382
A Study in Subjects With Neurogenic Orthostatic Hypotension
CuraSen Therapeutics
NCT07089043
Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
William Ondo, MD
NCT03229174
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neurogenic Orthostatic Hypotension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neurogenic Orthostatic Hypotension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neurogenic Orthostatic Hypotension page
5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Neurogenic Orthostatic Hypotension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vanderbilt University Medical Center sponsors the most Neurogenic Orthostatic Hypotension trials on record, review their full trial history before evaluating a specific study. See Vanderbilt University Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurogenic Orthostatic Hypotension condition card totals 5 registered trials; most-linked intervention Placebo; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.